Post-approval studies (Phase 4)Study completedNCT00220922
What this trial is testing
Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.
Who this might be right for
Multiple Sclerosis
Teva Neuroscience, Inc. 50